Skip to main content
. 2020 May 31;37(6):114. doi: 10.1007/s11095-020-02816-w

Fig. 6.

Fig. 6

Similarity assessment of the specificity of ABP 710 and infliximab RP. (a) Binding of LTα using SPR; (b) inhibition of LTα-induced IL-8 release in HUVEC by ABP 710 and infliximab RP.